Evidence map›Paper›PMID 34365895›Full record

ArticleGut microbes

Claudio Salaris, Melania Scarpa, Marina Elli, Alice Bertolini, Simone Guglielmetti, Fabrizio Pregliasco, Paola Brun, Ignazio Castagliuolo

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Microorganisms · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Safety Assessment ofMicroorganisms · 2025
    Article
  7. Review
  8. Heat-killedFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Nutrients · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Antiviral Effects and Underlying Mechanisms of Probiotics as Promising Antivirals.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Claudio SalarisDepartment of Molecular Medicine, University of Padua, Padua, Italy.
Melania ScarpaLaboratory of Advanced Translational Research, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.ORCID 0000-0002-7055-635X
Marina ElliAAT-Advanced Analytical Technologies S.r.l., Fiorenzuola d'Arda, Piacenza, Italy.
Alice BertoliniDepartment of Molecular Medicine, University of Padua, Padua, Italy.
Simone GuglielmettiDepartment of Food, Environmental and Nutritional Sciences (Defens), University of Milan, Milan, Italy.
Fabrizio PregliascoIRCCS Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy.
Paola BrunDepartment of Molecular Medicine, University of Padua, Padua, Italy.ORCID 0000-0002-3279-9000
Ignazio CastagliuoloDepartment of Molecular Medicine, University of Padua, Padua, Italy.ORCID 0000-0001-9888-7030
University of Padua · ITUniversity of Milan · ITIstituto Oncologico Veneto · ITSabalan University of Advanced Technologies · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing global pandemic of coronavirus disease 2019 (COVID-19), which primarily manifests with respiratory distress and may also lead to symptoms associated with the gastrointestinal tract. Probiotics are living microorganisms that have been shown to confer immune benefits. In this study, we investigated the immunomodulatory effects and anti-SARS-CoV-2 activity of three different

Indexed as

Antiviral AgentsCaco-2 CellsCOVID-19HumansLactobacillusLactoferrinPandemicsSARS-CoV-2Antiviral AgentsLactoferrinantiviral immunitycovid-19lactobacillilactoferrinProbioticssars-Cov-2

Identifiers

PMID34365895
PMCPMC8354669
OpenAlexW3188904026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.